Blood Journal/X
Jun 7, 2025, 10:28
IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
The Blood Journal featured a post highlighting the published article on X:
“Hallmarks of IL-10 deficiency predict R-CHOP response but reflect poor antitumor immunity in preclinical models and patients with DLBCL.”
Title: IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy
Authors: Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Marién Pascual, Enrique Goñi, Iñigo Clemente-Larramendi, Sandra Morales-Sánchez, María A. Burrell, Oscar Blanco, Adrián Arnaiz-Leché, Blanca S. Berrozpe, Maria Amann, Christian Klein, Pablo Umaña, Miguel Canales, José Ángel Martínez-Climent, Juan J. Lasarte, Pablo Sarobe, Francisco J. Novo, Sergio Roa
Find more posts on Hemostasis Today.
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership
-
Jul 10, 2026, 15:11Thirunavukkarasu Angappan: The Geopolitics of Plasma Supply and Self-Sufficiency
-
Jul 10, 2026, 14:51Danielle Boyle: Global Collaboration Takes Center Stage at ISTH 2026
-
Jul 10, 2026, 14:29Beril Awuor: The Functional Architecture of Blood and Its Physiological Significance